We must have a RS to get the share price highrer allowing institutional investors to BUY !!! PRH | PVCT Message Board Posts

Provectus Biopharmaceuticals, Inc.

  PVCT website

PVCT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  53702 of 54437  at  7/12/2020 1:18:59 PM  by

JerryC


 In response to msg 53699 by  BackMagic
view thread

Re: We must have a RS to get the share price highrer allowing institutional investors to BUY !!! PRH management can't even advance the sp a couple of cents let alone get it in $3-$5 /share so

Without many more changes, a RS accomplishes very little.
 
  • $20m market cap is too small for institutions.
  • Under $5,000 daily volume makes it impossible to build a meaningful position.
  • There's no story that would interest institutions.
  • Management team is unknown and unproven.
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 112
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
53703 Re: We must have a RS to get the share price highrer allowing institutional investors to BUY !!! PRH management can't even advance the sp a couple of cents let alone get it in $3-$5 /share so Xpizmo 0 7/12/2020 4:18:25 PM






Financial Market Data provided by
.


Loading...